Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Terminated"
topic_facet:"Carcinoma"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&filter%5B%5D=topic_facet%3A%22Carcinoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&filter%5B%5D=topic_facet%3A%22Carcinoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&filter%5B%5D=topic_facet%3A%22Carcinoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (674)
1
Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected Primary : UPCC06820 Phase 1 Trial of Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected Primary
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer : Phase II Study for the Evaluation of Neoadjuvant Treatment With Cabozantinib Pior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
KHK2455 (IDO Inhibitor) Plus Avelumab in Adult Subjects With Advanced Bladder Cancer : An Open-label, Phase 1 Study of KHK2455 in Combination With Avelumab in Adult Subjects With Locally Advanced or Metastatic Urothelial Carcinoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Study of Atezolizumab (Anti-Pd-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck : A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab (Anti-Pd-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Study of INCB086550 in Select Solid Tumors : A Phase 2 Study of INCB086550 (Oral PD-L1 Inhibitor) in Participants Who Are Immune Checkpoint Inhibitor-Naïve With Selected Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors : A Phase 1b/2, Multicenter, Open-Label Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors Nivolumab or Pembrolizumab in Adult Patients With Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary : Single-arm Phase 2 Study to Examine Pembrolizumab and Concurrent Radiation to Induce an Abscopal Effect in Patients With Previously Treated Carcinoma of Unknown Primary (CUP16-268)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer : Biomarker Modulation by Alpelisib (BYL719) in Transorally Resectable, HPV-Associated HNSCC: A Phase II Window Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors : Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for Unresectable Locally Advanced or Metastatic Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors : Phase II Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[68]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Recruitment Status: Terminated
Filter aufheben
Thema: Carcinoma
Medienart
674
Aufsätze
674
E-Artikel
674
E-Ressourcen
Zeitschriftentitel
674
ClinicalTrials.gov
Thema
674
610
Carcinoma
Recruitment Status: Terminated
674
Study Type: Interventional
288
Phase: Phase 2
139
Carcinoma, Squamous Cell
137
Carcinoma, Hepatocellular
133
Phase: Phase 1
110
Carcinoma, Renal Cell
95
Squamous Cell Carcinoma of Head and Neck
67
Carcinoma, Non-Small-Cell Lung
57
Phase: Phase 3
49
Lung Neoplasms
49
Medical Condition: Hepatocellular Carcinoma
49
Phase: Phase 1/Phase 2
46
Carcinoma, Transitional Cell
43
Phase: Phase 1, Phase 2
42
Breast Neoplasms
37
Neoplasms
28
Nasopharyngeal Carcinoma
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
349
2020-
317
2010-2019
8
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
674
Englisch
Haven't found what you're looking for?
Wird geladen...